San Francisco, CA, United States of America

Byung-Ju Jin

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Byung-Ju Jin. Retrieved from https://idiyas.com/inventor/byung-ju-jin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Byung-Ju Jin: Innovator in High-Content Drug Screening

Introduction: Byung-Ju Jin is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of drug screening, particularly through his innovative methods and systems. His work focuses on enhancing the efficiency of screening candidate agents that may modulate the activity of cultured cells.

Latest Patents: Byung-Ju Jin holds 1 patent for his invention titled "Methods for high-content drug screening." This patent provides methods and systems for screening candidate agents to determine their effects on cultured cells. The invention also includes compositions designed for the screening process, showcasing Jin's commitment to advancing drug discovery.

Career Highlights: Jin is affiliated with the University of California, where he continues to engage in research and development. His work has positioned him as a key figure in the academic and scientific community, contributing to the understanding of drug interactions at the cellular level.

Collaborations: Jin has collaborated with notable colleagues, including Alan S. Verkman and Sujin Lee. These partnerships have further enriched his research and expanded the impact of his innovations in drug screening.

Conclusion: Byung-Ju Jin's contributions to high-content drug screening exemplify the importance of innovation in the medical field. His work not only enhances the understanding of drug interactions but also paves the way for future advancements in drug discovery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…